Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed older notices including Revision: v3.4.1. These are administrative updates to the site history and do not change core study information or user-facing content.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a government-funding notice and updates the site revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedIntroduces a Show glossary option and color-coded highlights for additions and deletions in the study record history, with revision notes updated to v3.4.0 and removal of 'No FEAR Act data'.SummaryDifference0.5%

- Check42 days agoChange DetectedThe history page now includes a new revision entry (v3.3.4) and removes the previous v3.3.3, reflecting an administrative update to the record.SummaryDifference0.1%

- Check64 days agoChange DetectedNew revision notice added: Revision: v3.3.3, and Revision: v3.3.2 removed, along with deletion of the HHS Vulnerability Disclosure link in the footer; these are routine maintenance updates that do not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page. This is a site-version update and does not modify study details or historical records.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.